1 |
Schlaepfer, E., Audige, A., Von Beust, B., Manolova, V., Weber, M., Jollerm H., Bachemann, M. F., kundig, T. M. and Speck, R. F. (2004) CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo. J. Virol. 78, 12344-12354.
DOI
ScienceOn
|
2 |
Nguyen, M. T., Awale, S., Tezuka, Y., Tran, Q. L., Watanabe, H. and Kadota, S. (2004) Xanthine oxidase inhibitory activity of Vietnamese medicinal plants. Biol. Pharm. Bull. 27, 1414-1421.
DOI
ScienceOn
|
3 |
Ma, J., Starck, S. R. and Hecht, S. M. (1999) DNA polymerase beta inhibitors from Tetracera boiviniana. J. Nat. Prod. 62, 1660-1663.
DOI
ScienceOn
|
4 |
Dierynck, I., De Wit, M., Gustin, E., Keuleers, I., Vandersmissen, J., Hallenverger, S. and Hertogs, K. (2007) Binding kinetics of darunavir to human immunodeficiency virus type 1 protease explain the potent antiviral activity and high genetic barrier. J. Virol. 81, 13845-13851.
DOI
ScienceOn
|
5 |
Blanco, J. L., Varghese, V., Rhee, S. Y., Gatell, G. M. and Shafer, R. W. (2011) HIV-1 integrase inhibitor resistance and its clinical implications. J. Infect. Dis. 203, 1204-1214.
DOI
ScienceOn
|
6 |
Ji, C., Kopetzki, E., Jekle, A., Stubenrauch, K. G., Liu, X., Zhang, J., Rao, E., Schlothauer, T., Fischer, S., Cammack, N., Heilek, Ries, S. and Sankuratri, S. (2009) CD4-anchoring HIV-1 fusion inhibitor with enhanced potency and in vivo stability. J. Biol. Chem. 284, 5175-5185.
DOI
ScienceOn
|
7 |
Zhou, N., Nowicka-Sans, B., Zhang, S., Fna, L., Fang, J., Fang, H., Eggers, B., Fanglet, D. R., Wang, T., Kadow, J., Grasela, D., Hanna, G. J., Alexander, L., Colonno, R., Krystal, M. and Lin, P. F. (2011) In vivo patterns of resistance to the HIV attachment inhibitor BMS-488043. Antimicrob. Agents Chemother 55, 729-737.
DOI
ScienceOn
|
8 |
Adamson, C. S., Ablan, S. D., Boeras, I., Goila-Gaur, R., Soheilian, F., Nagashima, K., Li, F., Salzwedel, K., Sakalian, M., Wild, C. T. and Freed, E. O. (2006) In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat). J. Virol. 80, 10957-10971.
DOI
ScienceOn
|
9 |
Adamson, C. S., Waki, K., Ablan, S. D., Salzwedel, K. and Freed, E. O. (2009) Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457). J. Virol. 83, 4884-4894.
DOI
ScienceOn
|
10 |
Feng, J. Y., Ly, J. K., Myrick, F., Goodman, D., White, K. L., Svarovskaia, E. S., Borroto, K. and Miller, M. D. (2009) The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study. Retrovirology 6, 44.
DOI
ScienceOn
|
11 |
King, R. W. King, klabe, R. M., Reid, C. D. and Erickson- Viitanen, S. K. (2002) Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors. Antimicrob. Agents Chemother 46, 1640-1646.
DOI
ScienceOn
|
12 |
Notka, F., Meier, G. and Wagner, R. (2004) Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo. Antiviral. Res. 64, 93-102.
|
13 |
Fujioka, T., Kashiwada, Y., Kikuskie, R. E., Cosentino, L. M., Ballas, L. M., Jiang, J. B., Janzen, W. P., Chen, I. S. and Lee, K. H. (1994) Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J. Nat. Prod. 57, 243-247.
DOI
ScienceOn
|
14 |
Kashman, Y., Gustafson, K. R., Fuller, R. W., Cardellina, J. H., McMahon, J. B., Currends, M. J., Buckheit, R. W., Jr., Hughes, S. H., Cragg, G. M. and Boyd, M. R. (1992) The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J. Med. Chem. 35, 2735-2743.
DOI
|
15 |
Johnson, S. C. and Gerber, J. G. (2000) Advances in HIV/AIDS therapy. Adv. Intern. Med. 45, 1-40.
|
16 |
Zhu, H. (1992) The tropical rainforest vegetation in Xishuangbanna. Chinese Geographical Science. 2, 64-73.
DOI
ScienceOn
|
17 |
Lee, M. S., Kim, C. H., Hoang, D. M., Kim, B. Y., Sohn, C. B., Kim, M. R. and Ahn, J. S. (2009) Genistein-derivatives from Tetracera scandens stimulate glucose-uptake in L6 myotubes. Biol. Pharm. Bull. 32, 504-508.
DOI
ScienceOn
|
18 |
Umar, A., Ahmed, Q. U., Muhammad, B. Y., Dogarai, B, B and Soad, S. Z. (2010) Anti-hyperglycemic activity of the leaves of Tetracera scandens Linn. Merr. (Dilleniaceae) in alloxan induced diabetic rats. J. Ethnopharmacol. 131, 140-145.
DOI
ScienceOn
|
19 |
Hupfeld, J. and Efferth, T. (2009) Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products. In Vivo 23, 1-6.
|
20 |
Latinovic, O., Kuruppu, J., Dacis, C., Le, N. and Heredia, A. (2009) Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc. Clin. Med. Ther. 1, 1497-1510.
|
21 |
Yogeeswari, P. and Sriram, D. (2005) Betulinic acid and its derivatives: a review on their biological properties. Curr. Med. Chem. 12, 657-666.
DOI
ScienceOn
|